Literature DB >> 9026270

Hypothalamic-pituitary-adrenal axis in WBN/Kob rats with non-insulin dependent diabetes mellitus.

C Tojo1, T Takao, T Nishioka, Y Numata, S Suemaru, K Hashimoto.   

Abstract

In an attempt to define the hypothalamic-pituitary-adrenal (HPA) axis in non-insulin dependent diabetic rats (WBN/Kob), we measured plasma corticotropin releasing factor (CRF), as well as arginine vasopressin (AVP), ACTH, and corticosterone (B), CRF concentrations in the median eminence (ME), the remainder of the hypothalamus (rHY) and the neurointermediate lobe of the pituitary (NIL). We also measured Iodine-125-labeled ovine CRF ([125I]oCRF) binding in the brain and peripheral tissues. Body and thymus weight in WBN/Kob rats were significantly lower than in control Wistar rats, but adrenal weight was higher in WBN/Kob rats. Plasma ACTH levels were significantly higher in WBN/Kob rats than in the control rats. However, plasma CRF, AVP and B levels in WBN/Kob rats were not different from those in the control rats. The CRF concentration was significantly decreased in the ME of the diabetic rats, compared with control rats, but CRF concentrations in the rHY and NIL were unchanged in the two groups. A significant reduction in [125I]oCRF binding in the anterior pituitary was demonstrated in WBN/Kob rats, but no significant difference between the diabetic and control rats in CRF binding was observed in the frontal cortex, spleen or adrenal gland. These findings suggest that the HPA axis is chronically stimulated in the non-insulin dependent diabetic rats.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9026270     DOI: 10.1507/endocrj.43.233

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  5 in total

Review 1.  The role of insulin resistance in the pathogenesis of Alzheimer's disease: implications for treatment.

Authors:  G Stennis Watson; Suzanne Craft
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

Review 2.  Cognitive dysfunction and diabetes mellitus.

Authors:  Christopher T Kodl; Elizabeth R Seaquist
Journal:  Endocr Rev       Date:  2008-04-24       Impact factor: 19.871

3.  Views and opinion on BDNF as a target for diabetic cognitive dysfunction.

Authors:  Allam Appa Rao
Journal:  Bioinformation       Date:  2013-06-29

Review 4.  Diabetes cognitive impairments and the effect of traditional chinese herbs.

Authors:  Xiaohan Xu; Leilei Guo; Guoqing Tian
Journal:  Evid Based Complement Alternat Med       Date:  2013-12-09       Impact factor: 2.629

5.  Ocular lesions in leptin receptor-deficient medaka (Oryzias latipes).

Authors:  Shin-Ichi Chisada; Ayano Hirako; Akihiko Sugiyama
Journal:  J Toxicol Pathol       Date:  2017-10-15       Impact factor: 1.628

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.